Timing of adverse events during maintenance treatment with rucaparib for recurrent ovarian cancer in the phase III ARIEL3 study Meeting Abstract


Authors: Dean, A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Colombo, N.; Weberpals, J.; Clamp, A. R.; Scambia, G.; Leary, A.; Holloway, R. W.; Gancedo, M. A.; Fong, P. C.; Goh, J. C.; O'Malley, D. M.; Cameron, T.; Maloney, L.; Goble, S.; Coleman, R. L.; Ledermann, J. A.
Abstract Title: Timing of adverse events during maintenance treatment with rucaparib for recurrent ovarian cancer in the phase III ARIEL3 study
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S620
End Page: S621
Language: English
ACCESSION: WOS:000573469101109
DOI: 10.1016/j.annonc.2020.08.960
PROVIDER: wos
Notes: Meeting Abstract: 821P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors